228 related articles for article (PubMed ID: 32426928)
1. The diabetic lung: An easy target for SARS-CoV-2?
Caruso I; Giorgino F
Diabetes Metab Res Rev; 2020 Nov; 36(8):e3346. PubMed ID: 32426928
[No Abstract] [Full Text] [Related]
2. COVID 19 could trigger global diabetes burden - A hypothesis.
Mukherjee S; Banerjee O; Singh S; Maji BK
Diabetes Metab Syndr; 2020; 14(5):963-964. PubMed ID: 32604015
[No Abstract] [Full Text] [Related]
3. Diabetes care during COVID-19 lockdown at a tertiary care centre in India.
Joshi R; Atal S; Fatima Z; Balakrishnan S; Sharma S; Joshi A
Diabetes Res Clin Pract; 2020 Aug; 166():108316. PubMed ID: 32673697
[TBL] [Abstract][Full Text] [Related]
4. The Coronavirus 2019 Pandemic and Diabetes: An International Perspective.
Klonoff DC
J Diabetes Sci Technol; 2020 Jul; 14(4):703-704. PubMed ID: 32517506
[No Abstract] [Full Text] [Related]
5. Prevalence and impact of diabetes among people infected with SARS-CoV-2.
Fadini GP; Morieri ML; Longato E; Avogaro A
J Endocrinol Invest; 2020 Jun; 43(6):867-869. PubMed ID: 32222956
[No Abstract] [Full Text] [Related]
6. Diabetes and COVID-19: Global and regional perspectives.
Jeong IK; Yoon KH; Lee MK
Diabetes Res Clin Pract; 2020 Aug; 166():108303. PubMed ID: 32623038
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.
Chan KH; Thimmareddygari D; Ramahi A; Atallah L; Baranetsky NG; Slim J
Diabetes Res Clin Pract; 2020 Aug; 166():108279. PubMed ID: 32592843
[TBL] [Abstract][Full Text] [Related]
8. Symmetric cutaneous vasculitis in COVID-19 pneumonia.
Castelnovo L; Capelli F; Tamburello A; Faggioli PM; Mazzone A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e362-e363. PubMed ID: 32378747
[No Abstract] [Full Text] [Related]
9. Covid-19 and Diabetes: A Complex Bidirectional Relationship.
Muniangi-Muhitu H; Akalestou E; Salem V; Misra S; Oliver NS; Rutter GA
Front Endocrinol (Lausanne); 2020; 11():582936. PubMed ID: 33133024
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-induced atypical pulmonary lymphocytes.
Vergé V; Soufan R
Blood; 2020 Nov; 136(19):2241. PubMed ID: 33152090
[No Abstract] [Full Text] [Related]
11. Cutaneous manifestation of COVID-19 in images: a case report.
Avellana Moreno R; Estela Villa LM; Avellana Moreno V; Estela Villa C; Moreno Aparicio MA; Avellana Fontanella JA
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e307-e309. PubMed ID: 32330339
[No Abstract] [Full Text] [Related]
12. Commentary: COVID-19 in patients with diabetes.
Hill MA; Mantzoros C; Sowers JR
Metabolism; 2020 Jun; 107():154217. PubMed ID: 32220611
[No Abstract] [Full Text] [Related]
13. Did Whatsapp
Duong TA; Velter C; Rybojad M; Comte C; Bagot M; Sulimovic L; Bouaziz JD
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e348-e350. PubMed ID: 32330322
[No Abstract] [Full Text] [Related]
14. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.
Janah H; Zinebi A; Elbenaye J
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e373-e375. PubMed ID: 32386446
[No Abstract] [Full Text] [Related]
15. Diabetes and COVID-19: A systematic review on the current evidences.
Abdi A; Jalilian M; Sarbarzeh PA; Vlaisavljevic Z
Diabetes Res Clin Pract; 2020 Aug; 166():108347. PubMed ID: 32711003
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and sickle cell disease.
Menapace LA; Thein SL
Haematologica; 2020 Nov; 105(11):2501-2504. PubMed ID: 33131239
[No Abstract] [Full Text] [Related]
17. Acral cutaneous lesions in the time of COVID-19.
Recalcati S; Barbagallo T; Frasin LA; Prestinari F; Cogliardi A; Provero MC; Dainese E; Vanzati A; Fantini F
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e346-e347. PubMed ID: 32330324
[No Abstract] [Full Text] [Related]
18. Related molecular mechanisms of COVID-19, hypertension, and diabetes.
Akkus E; Sahin M
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E881. PubMed ID: 32479159
[No Abstract] [Full Text] [Related]
19. Cutaneous manifestations in COVID-19: a first perspective.
Recalcati S
J Eur Acad Dermatol Venereol; 2020 May; 34(5):e212-e213. PubMed ID: 32215952
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.
Balestri R; Rech G; Girardelli CR
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e357-e358. PubMed ID: 32358791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
